X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211443
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213513
https://www.raps.org/news-and-articles/news-articles/2020/3/fda-requires-boxed-warning-for-singulair-generics
https://endpts.com/fda-requires-boxed-warning-for-singulair-and-its-generics/
https://www.indiainfoline.com/article/news-top-story/glenmark-pharma-receives-approval-from-russian-ministry-of-healthcare-to-market-montlezir-119093000069_1.html
https://endpts.com/merck-touts-phase-iii-data-for-antibacterial-recarbrio-sanofi-to-ax-200-jobs-in-japan-report/
https://www.fiercepharma.com/pharma/xofluza-hand-roche-offloads-tamiflu-u-s-otc-switch-rights-to-sanofi
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210914
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211983
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211551
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211528
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211528
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-xyzal-allergy-levocetirizine-dihydrochloride-oral-solution-1529039977.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210375
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204599
http://www.fiercepharma.com/marketing/sanofi-s-xyzal-debuts-first-ad-campaign-enters-allergy-otc-wars-wise-old-spokes-owl
http://www.news.sanofi.us/2017-02-01-Sanofis-Xyzal-R-Allergy-24HR-Approved-for-Over-the-Counter-Use-in-the-United-States
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204323
http://businesstoday.intoday.in/story/dr-reddy-lab-completes-acquisition-of-ucb-select-brands/1/220770.html
http://www.fiercepharma.com/story/ucb-hands-over-south-asia-branded-drugs-dr-reddys-latest-slimdown-plan/2015-04-01
Market Place
Share 
